Meanwhile, it was found that FTO overexpression did not promote NSCLC cell proliferation and invasion after mutation, suggesting that the oncogenic effect of FTO on NSCLC may mainly depend on its catalytic activity (Liu et al., 2018). This evidence concerns the gene FTO and non-small cell lung carcinoma.